- Study Suggests a PARP Inhibitors Has Wider Cancer Applications.
- [No author given]
- Inside Precision Medicine. Topics. Oncology. 2022 Nov 9.
- Research news
- Free Full Text
•• Original research:
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.